In our study PTX3 values were significantly higher in patients over 60 years and in those with obesity (body mass index (BMI) ≥30), cardiovascular diseases and continuous systemic cortisone treatment (daily dose over 10 mg oral prednisolone) compared to those without these risk factors. This evidence concerns the gene PTX3 and obesity due to melanocortin 4 receptor deficiency.